Inari Medical Partners With American Venous Forum And National Blood Clot Alliance On DEFIANCE Trial To Evaluate ClotTriever System For Deep Vein Thrombosis Treatment
Portfolio Pulse from Benzinga Newsdesk
Inari Medical has partnered with the American Venous Forum and the National Blood Clot Alliance to conduct the DEFIANCE trial. This trial will evaluate the effectiveness of Inari's ClotTriever System in treating deep vein thrombosis.
October 15, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inari Medical is conducting the DEFIANCE trial in partnership with the American Venous Forum and the National Blood Clot Alliance to evaluate its ClotTriever System for deep vein thrombosis treatment.
The partnership and trial could lead to positive outcomes for Inari Medical if the ClotTriever System proves effective, potentially increasing demand and market share. This news is highly relevant and important for investors as it directly involves Inari's product development and market strategy.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100